The Texas Department of Public Safety’s latest data for November 2023 provides an impactful snapshot into the state of Texas medical cannabis landscape. These statistics unveil a perspective on large patient and limited physician growth, as well as the current state of accessibility within the Lone Star State.

Patient Growth:
In November 2023, Texas witnessed an increase in registered patients, reaching a total of 70,835. This marks a notable 3% growth from the previous month, showcasing the state’s sustained momentum in medical cannabis sign ups. Comparing this figure to the same month in the previous year, the patient count has surged by an impressive 72%, indicating a robust upward trend in demand that has created the hockey stick shape below.

Texas Medical Cannabis Patient Count Nov 2023. TexMed by YesCannabis.

Physician Registration:
The state’s physicians that prescribe medical cannabis has also experienced growth, with 772 registered physicians documented in the latest November data. This represents a steady 1% increase from the previous month, reflecting ongoing engagement and interest among healthcare professionals. Over the past year, the number of registered physicians has seen a substantial 18% growth, indicating positive trends in attracting and retaining medical practitioners.

Texas Medical Cannabis Doctor Count. TexMed by YesCannabis.

Patient-to-Physician Ratio:
The patient-to-physician ratio currently stands at 92 patients per physician. This ratio has grown by 2% from the previous month, underscoring the increased demand for healthcare services. Over the past year, there has been a significant 46% growth in the patient-to-physician ratio, emphasizing the ongoing challenges in healthcare access and the importance of optimizing the distribution of medical resources.

Access to Medical Products:
A striking observation pertains to the limited access to medical products for the 70,835 registered patients. Presently, only three active companies facilitate access, with fewer than 30 locations available for patients who actively participate in the program. This highlights a significant gap in accessibility and emphasizes the pressing need for broader availability and increased options for patients to ensure comprehensive and effective healthcare delivery.

Relative Scale:
In a state as vast as Texas, boasting a population of 30,000,000, the 70,835 registered medical cannabis patients constitute only 0.2% of the total population. This statistic serves as a compelling reminder of the considerable potential for further expansion and development in the state’s medical cannabis program. The relatively low percentage underscores the opportunity to enhance outreach efforts, engage more residents, and address the healthcare needs of a larger portion of the population.

November 2023 data showcases positive trends in patient and physician growth, highlighting the need for ongoing efforts to enhance medical cannabis healthcare infrastructure, accessibility, and the availability of medical cannabis products in Texas.

Comparison with Florida Medical Market

Florida’s Growing Patient Count

At the end of 2022, Marijuana Policy Project (MPP) reported that Florida had 831,775 registered patients, making up 3.74% of the state’s population. This highlights the increasing acceptance of medical cannabis as a viable treatment option.

Extensive Dispensary Network

To cater to this demand, Florida has 501 active dispensaries, operated by 22 different companies, with more on the way. This shows the competitive nature of the industry and ensures patients have convenient access to their prescribed treatments.

Florida’s Medical Cannabis Program is thriving, with a significant patient count and a robust dispensary network, exemplifying the program’s success and the growing role of medical cannabis in the state’s healthcare landscape.

 

News on the latest application round

More than 130 applications have been submitted to the Texas Department of Public Safety for vertically integrated medical marijuana dispensaries, marking a significant response since the reopening of applications in January after a four-year hiatus.

Despite a recent bill to expand the state’s medical marijuana program stalling in the Senate, the DPS reports no current plans for usage law expansion, emphasizing their commitment to ensuring statewide access to low-THC cannabis for registered patients. For further details, visit KVUE.

 

 

Watch the TexMed APP launch video on YouTube

If you’re looking to stay in tune with the Texas Medical market, please check out TexMedCannabis.com

EXPLORE MORE NEWS

Major Corporations Investing in Cannabis

As cannabis legalization continues to spread across the country, major corporations are increasingly taking notice and investing in the industry. In April of 2023, a major beverage company announced a $100 million investment in a cannabis-infused drink startup, signaling the growing trend of large corporations entering the cannabis space.

Los Angeles Launches Job Board for Local Cannabis Licenses, Boosting Social Equity Benefits

The city of Los Angeles has taken a significant step towards fostering a healthier and more equitable licensed cannabis market with the launch of a dedicated job board. This innovative initiative aims to connect individuals seeking employment opportunities in the cannabis industry with licensed businesses in the local Los Angeles area.

Maryland’s Cannabis Market on the Brink of Explosive Growth in 2024 with Upcoming Licensing Opportunities

In a remarkable turn of events, Maryland’s cannabis market has continued its upward trajectory, with sales in September reaching a staggering $90.5 million, just shy of the previous month’s record-breaking $91.7 million, as reported by the state’s Cannabis Administration (MCA). Even more impressive is the fact that September’s daily sales averaged over $3 million, despite having one fewer day than August. A significant portion of these sales, amounting to $54.3 million or 60%, stemmed from adult-use transactions, marking a notable increase from August’s 57.8%.

Revolutionary Shift: US Health Department Proposes Reclassifying Marijuana from Schedule I to Schedule III

In a groundbreaking move that has the potential to reshape the landscape of cannabis regulations, the U.S. Department of Health and Human Services (HHS) has taken a bold step by formally recommending the reclassification of marijuana from Schedule I to Schedule III under federal law. This historic decision signifies a seismic shift in perspective, indicating that the nation’s premier health agency no longer views cannabis as a substance with high abuse potential and zero medical value.

Newsletter